TY - JOUR
T1 - Medical care expenditure associated with body mass index in Japan
T2 - The Ohsaki Study
AU - Kuriyama, S.
AU - Tsuji, I.
AU - Ohkubo, T.
AU - Anzai, Y.
AU - Takahashi, K.
AU - Watanabe, Y.
AU - Nishino, Y.
AU - Hisamichi, S.
N1 - Funding Information:
The authors are grateful to Dr A Fukao for his valuable comments, and to Dr A Sasaki for his managing the project site, to Y Nakata, S Sato and R Taneichi for their helpful secretarial assistance. This study was supported by a Health Sciences Research Grant for Health Services (H10-025), Ministry of Health, Labour and Welfare, Japan.
Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - OBJECTIVE: To examine the impact of body mass index (BMI) upon medical care use and its costs in Japan. DESIGN: A population-based prospective cohort study from 1995 to 1998. SUBJECTS: A cohort of 41 967 Japanese adults aged 40-79y. Subjects who died during the first year of follow-up, or who at baseline reported having had cancer, myocardial infarction, stroke or kidney disease were excluded. MEASUREMENTS: Medical care use and its costs, actual charges, by linkage with the National Health Insurance claim history files after adjustment of smoking, drinking and physical functioning status. RESULTS: There was a U-shaped association between BMI and total medical costs. The nadir of the curve was found at a BMI of 21.0-22.9 kg/m2. Relative to the nadir, total costs were 9.8% greater among those with BMIs of 25.0-29.9 (rate ratio, 1.10; 95% confidence interval (CI), 1.03-1.17), and 22.3% greater among those with BMIs of 30.0 or higher (rate ratio, 1.22; 95% CI, 1.08-1.37). Estimated excess direct costs attributable to overweight (BMI of 25.0-29.9kg/m2) and obesity (BMI of 30.0 kg/m2 or higher) represent 3.2% of total health expenditure in the present study, which is within the range reported in Western countries (0.7-6.8%). CONCLUSION: Our prospective data demonstrate that the impact of overweight and obesity upon medical care costs in Japan is as large as in Western countries, despite the much lower mean BMI in Japanese populations.
AB - OBJECTIVE: To examine the impact of body mass index (BMI) upon medical care use and its costs in Japan. DESIGN: A population-based prospective cohort study from 1995 to 1998. SUBJECTS: A cohort of 41 967 Japanese adults aged 40-79y. Subjects who died during the first year of follow-up, or who at baseline reported having had cancer, myocardial infarction, stroke or kidney disease were excluded. MEASUREMENTS: Medical care use and its costs, actual charges, by linkage with the National Health Insurance claim history files after adjustment of smoking, drinking and physical functioning status. RESULTS: There was a U-shaped association between BMI and total medical costs. The nadir of the curve was found at a BMI of 21.0-22.9 kg/m2. Relative to the nadir, total costs were 9.8% greater among those with BMIs of 25.0-29.9 (rate ratio, 1.10; 95% confidence interval (CI), 1.03-1.17), and 22.3% greater among those with BMIs of 30.0 or higher (rate ratio, 1.22; 95% CI, 1.08-1.37). Estimated excess direct costs attributable to overweight (BMI of 25.0-29.9kg/m2) and obesity (BMI of 30.0 kg/m2 or higher) represent 3.2% of total health expenditure in the present study, which is within the range reported in Western countries (0.7-6.8%). CONCLUSION: Our prospective data demonstrate that the impact of overweight and obesity upon medical care costs in Japan is as large as in Western countries, despite the much lower mean BMI in Japanese populations.
KW - Body mass index
KW - Cohort studies
KW - Health care costs
KW - Health expenditures
KW - Japan
UR - http://www.scopus.com/inward/record.url?scp=0036345983&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036345983&partnerID=8YFLogxK
U2 - 10.1038/sj.ijo.0802021
DO - 10.1038/sj.ijo.0802021
M3 - Article
C2 - 12119572
AN - SCOPUS:0036345983
SN - 0307-0565
VL - 26
SP - 1069
EP - 1074
JO - International Journal of Obesity
JF - International Journal of Obesity
IS - 8
ER -
